Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T07217 | Target Info | |||
Target Name | Fatty acid-binding protein 4 (FABP4) | ||||
Synonyms | Fatty acid-binding protein, adipocyte; Adipocyte-type fatty acid-binding protein; Adipocyte lipid-binding protein; Adipocyte fatty-acid-binding protein; Adipocyte fatty binding protein; ALBP; AFABP; A-FABP | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | FABP4 | ||||
Biochemical Class | Fatty acid binding protein | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | diphenylamine-2-carboxylic acid | Ligand Info | |||
Canonical SMILES | C1=CC=C(C=C1)NC2=CC=CC=C2C(=O)O | ||||
InChI | 1S/C13H11NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9,14H,(H,15,16) | ||||
InChIKey | ZWJINEZUASEZBH-UHFFFAOYSA-N | ||||
PubChem Compound ID | 4386 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6LJW Crystal structure of human FABP4 in complex with a novel inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | No | [1] |
PDB Sequence |
RGSHMCDAFV
5 GTWKLVSSEN15 FDDYMKEVGV25 GFATRKVAGM35 AKPNMIISVN45 GDVITIKSES 55 TFKNTEISFI65 LGQEFDEVTA75 DDRKVKSTIT85 LDGGVLVHVQ95 KWDGKSTTIK 105 RKREDDKLVV115 ECVMKGVTST125 RVYERA
|
|||||
|
||||||
PDB ID: 6LJX Crystal structure of human FABP4 in complex with a novel inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.75 Å | Mutation | No | [1] |
PDB Sequence |
RGSHMADAFV
5 GTWKLVSSEN15 FDDYMKEVGV25 GFATRKVAGM35 AKPNMIISVN45 GDVITIKSES 55 TFKNTEISFI65 LGQEFDEVTA75 DDRKVKSTIT85 LDGGVLVHVQ95 KWDGKSTTIK 105 RKREDDKLVV115 ECVMKGVTST125 RVYERA
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J Med Chem. 2020 Apr 23;63(8):4090-4106. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.